On a population basis, a study published this month shows prevalence is now 254.8 cases of ulcerative colitis and 77.0 cases ...
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European ...
The 28-year-old defender is now supporting IBD research by the Royal Devon University Healthcare NHS Foundation Trust and the ...
Turmeric, featuring its active compound curcumin, provides powerful anti-inflammatory and antioxidant benefits. This ancient ...
SAN DIEGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will ...
FDA approves Johnson & Johnson's Tremfya for children with plaque psoriasis and psoriatic arthritis. Read more here.
Introducing The Mane Event, a series where we explore how hair loss (and hair regrowth) has become part of the culture at ...
The FDA has approved Johnson & Johnson’s TREMFYA for children aged 6+ weighing at least 40 kg with moderate to severe plaque ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...
Introducing The Mane Event, a series where we explore how hair loss (and hair regrowth) has become part of the culture at ...
Everyday Health on MSN
6 Popular Supplements That May Have Hidden Dangers
Medications that dont mix well with vitamin D include the weight loss drug orlistat (Xenical, Alli), various statins, such as ...
The Royal Devon University Healthcare NHS Foundation Trust and the University of Exeter have launched the RAPID-IBD study to speed up diagnosis o ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback